Is Radical Prostatectomy Feasible in All Cases of Locally Advanced Non-Bone Metastatic Prostate Cancer? Results of a Single-Institution Study

European Urology

Volumn 51, Issue 4, 2007, Pages 922-930

  Gontero, Paolo ^a   Marchioro, Giansilvio ^b   Pisani, Roberta ^b   Zaramella, Stefano ^b   Sogni, Filippo ^b   Kocjancic, Ervin ^b   Mondaini, Nicola ^c   Bonvini, Daniele ^b   Tizzani, Alessandro ^a   Frea, Bruno ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Advanced prostate cancer; Morbidity; Radical prostatectomy; Survival

Indexed keywords

BICALUTAMIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TRANSFUSION; BONE METASTASIS; CANCER SURVIVAL; HUMAN; KAPLAN MEIER METHOD; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; OPERATION DURATION; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURGEON; SURGICAL TECHNIQUE; TIME SERIES ANALYSIS;

AGED; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 33847097826     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.08.050     Document Type: Article

References (24)

1. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
2. Steinberg G.D., Epstein J.I., Piantadosi S., and Walsh P.C. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144 (1990) 1425-1432
3. Gerber G.S., Thisted R.A., Chodak G.W., et al. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 32 (1997) 385-390
4. Moul J.W., and Paulson D.F. The role of radical surgery in the management of radiation recurrent and large volume prostate cancer. Cancer 68 (1991) 1265-1271
5. Ward J.F., and Zincke H. Radical prostatectomy for the patient with locally advanced prostate cancer [review]. Curr Urol Rep 4 (2003) 196-204
6. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
7. Bolla M., Collette L., Blank L., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360 (2002) 103-106
8. Laverdiere J., Gomez J.L., Cusan L., et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 247-252
9. Coen J.J., Zietman A.L., Thakral H., and Shipley W.U. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol 20 (2002) 3199-3205
10. Pilepich M.V., Winter K., John M.J., et al. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 50 (2001) 1243-1252
11. Padula G.D., Zelefsky M.J., Venkatraman E.S., et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 439-443
12. Lerner S.E., Blute M.L., and Zincke H. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J Urol 154 (1995) 1447-1452
13. Van Poppel H., Goethuys H., Callewaert P., Vanuytsel L., Van de Voorde W., and Baert L. Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer. Eur Urol 38 (2000) 372-379
14. Konety B.R., Eastham J.A., Reuter V.E., et al. Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. J Urol 171 (2004) 709-713
15. van den Ouden D., Hop W.C., and Schroder F.H. Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy [review]. J Urol 160 (1998) 1392-1397
16. Steuber T., Erbersdobler A., Graefen M., et al. Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy. Cancer 106 (2006) 775-782
17. Gontero P., and Muir G.H. Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate? Letter. Eur Urol 34 (1998) 518-519
18. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277 (1997) 1445-1451
19. Heidenreich A., Ohlmann C.H., and Polyakov S. Anatomical extent of pelvic lymphadenectomy in bladder and prostate cancer. Eur Urol Suppl 4 4 (2005) 15-24
20. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1027
21. Van Poppel H. Surgery for clinical T3 prostate cancer. Eur Urol Suppl 4 4 (2005) 12-14
22. Hull G.W., Rabbani F., Abbas F., et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 167 (2002) 528-534
23. Crook J., Malone S., Perry G., et al. Postradiotherapy prostate biopsies: what do they really mean? Results from 498 patients. Int J Radiat Oncol Biol Phys 48 (2000) 355-367
24. Thompson I.A., Tangen C., Basler J., and Crawford E.D. Impact of previous local treatment for prostate cancer on subsequent metastatic disease. J Urol 168 (2002) 1008-1012